Pemetrexed disodium heptahydrate is an organic sodium salt and hydrate form of pemetrexed disodium. It functions as an antimetabolite and antineoplastic agent that inhibits thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 357166-29-1
Pemetrexed disodium hemipentahydrate
pharmaceutical raw material
Pemetrexed-Disodium
pharmaceutical raw material
Brivaracetam, (I+-S,4S)-
pharmaceutical raw material
Brivaracetam
pharmaceutical raw material
AR,4S-Brivaracetam
pharmaceutical raw material
AR-Brivaracetam
pharmaceutical raw material
D-Pemetrexed disodium
pharmaceutical raw material
Pemetrexed
active pharmaceutical ingredient
disodium;(2S)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioate;heptahydrate
QJVSMHJWAOSBMD-MYXYZBIASA-L
C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-].O.O.O.O.O.O.O.[Na+].[Na+]